top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
Autore Franco Marina Santiago
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (302 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato nanostructured lipid carriers
doxorubicin
mucositis
cell internalization
albumin
BSA
CPP
gold nanorods
gold nanoprisms
arginine-rich peptide
glutathione
nanoparticles
oxidative stress
breast cancer
gastric cancer
nanoparticle
fucoidan
d-alpha-tocopherylpoly (ethylene glycol) succinate
combination chemotherapy
G-quadruplex
nucleolin
DNA nanocages
intracellular localization
cancer targeting
molecular dynamics simulations
mesoporous silica nanoparticles
radiotherapy
immunotherapy
tumor microenvironment
abscopal effect
magnetofection in vivo
magnetic nanoparticles
iron oxide
gene delivery
gene vectors
codelivery nanocarriers
photodynamic therapy
anticancer therapies
combination therapy
phthalocyanine
uterine cervical neoplasms
photochemotherapy
in vitro
in vivo
nanocarrier
polyplexes
siRNA delivery
glioblastoma therapy
amphiphilic poly(α)glutamate
P-selectin
prodrug
drug delivery
targeted therapy
chemotherapy
prostate cancer
prostate-specific membrane antigen
targeted delivery
encapsulation
cabazitaxel
nanocarriers
nanosystems
radiosensitizer
hypoxia
synergism
cancer
photothermal therapy
combined antitumor effect
oxygenation
hydrogel
hypoxic tumor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595074103321
Franco Marina Santiago  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Delivery of siRNA Therapeutics
Drug Delivery of siRNA Therapeutics
Autore Lamberti Gaetano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (288 p.)
Soggetto topico Medicine
Soggetto non controllato AKT
amphiphilic dendrons
angiogenesis
antitumor effect
aptamers
asthma
BCL2
BIRC5/survivin
breast cancer
cancer
carbonate apatite
cationic cholesterol derivative
cationic liposome
clinical trials
covalent dendrimers
delivery
drug co-delivery
drug delivery
endoglin
endothelial cells
ERBB2
folate
folate receptor
gene knockdown
gene silencing
indocyanine green
intracellular release
iron oxide
light-activated release
lipid
liposome
liposomes
magnetic nanoparticle
methotrexate
migration
mixed micelles
n/a
NABDs
nanoparticle
nanoparticles
nanovectors
oligonucleotide delivery
oral cancer
ovarian cancer
PAMAM dendrimers
pegylation
PEI
peptide
poly(ethylene) imine
polyamine
polyaspartamide
polymer
polyplexes
proliferation
RNA
RNAi therapeutics
self-assembling
siRNA
siRNA delivery
STAT6
targeted delivery system
tumor xenograft
tumor-targeting
tyrosine-modification
VEGFA
VEGFR1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557498903321
Lamberti Gaetano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Self-Organizing Nanovectors for Drug Delivery
Self-Organizing Nanovectors for Drug Delivery
Autore Matricardi Pietro
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (186 p.)
Soggetto topico Medicine
Soggetto non controllato aerogel
amphiphilic random copolymers
anticancer
antimicrobial photodynamic therapy
astaxanthin
autophagy induction
betulinic acid
biofilms
bolaform amphiphilic lipids
bolalipids
C-peptide
caries prevention
chitosan
chorioallantoic membrane model
controlled release
curcumin
diabetes
diffusion barrier
doxorubicin
drug delivery
drug delivery system
drug delivery systems
encapsulation
eukaryotic vaults
gold nanoparticles
gold reduction
graphene quantum dots
hyaluronan
hydrogel
in situ gelling systems
intracellular therapy
irradiation cycles
laser treatment
liposomes
localized heating effect
mixed polymeric micelles
multidrug resistance
nano-assemblies
nanocage
nanohydrogels
nanoparticle
nanoparticles
nanovesicles
natural extracts
Oral antimicrobials
oxidative stress
pH/redox-responsive
photo-thermal therapy
polyelectrolyte complexes
polypeptides
protein self-assembly
pulmonary surfactant
resveratrol
self-assembly
siRNA delivery
squalene
syringeable implant
trehalose
triggered release
vapor nanobubbles
zoledronic acid
ISBN 3-03928-429-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404087803321
Matricardi Pietro  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (578 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ADAM17
adoptive T cell therapy
AKT
androgens
apoptosis
autoimmune disease
autosomal-dominant hyper IgE syndrome
Bone Marrow Failure Syndromes
breast cancer
cancer
cancer models
cancer progression
cancer-stem cell
CD38
CD4+ T cells
CD8+ T cells
cell cycle
cell hierarchy
chaperones
chemotherapy resistance
cirrhosis
colon cancer
companion animals
comparative oncology
cytokine
cytokine receptor signaling
dynamic programming
endoplasmic reticulum (ER) stress
epidermal growth factor receptor (EGF-R)
ERK1/2
escape mechanisms
gain-of-function mutation
glioblastoma
glioma
growth hormone insensitivity syndrome
heat shock proteins
hedging
hematopoietic cancers
hepatitis C virus (HCV)
hepatocellular carcinoma (HCC)
hepatocyte nuclear factor 4 alpha (HNF4A)
immune check point
immune suppression
immunosuppression
immunotherapy
inflammation
inflammation associated cancer
inflammatory hepatocellular adenomas
interleukin-6
JAK
JAK family of protein tyrosine kinases
JAK2 V617F
knockout
lipopolyplex
lung cancer
lymphocytes
lymphoma
M2 macrophages
melanoma
meta-analysis
metalloprotease
metastasis
microRNA-122 (miR-122)
mitochondria
MPN
mTOR
multiple myeloma
mutations
myeloid cells
myeloid leukemia
n/a
nanoparticle
neoplastic stem cells
NGS
NK cells
nuclear factor erythroid 2-related factor 2 (NRF2)
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
ovarian cancer
oxidative stress (OS)
PD-L1
PEI
pharmacological inhibitor
pharmacological inhibitors
polyethylenimine
post-decision state variable
prolactin
proliferation
prostate cancer
RHOA
risk management
S3I-1757
SH2 domain
shedding
signal transducer and activator of transcription
signal transducer and activator of transcription 3 (STAT3)
siRNA delivery
siRNA/RNAi
small-molecule inhibitors
solid cancers
stabilization
STAT
STAT transcription factors
STAT3
STAT3 inhibitor XIII
STAT5
STAT5 signaling
STAT5B signaling
stem/progenitor cells
stemness
T-cell large granular lymphocytic leukemia
T-cell leukemia
T-cell prolymphocytic leukemia
T-cells
T-PLL
targeted therapy
targeting
therapeutic targeting
therapy resistance
trans-signaling
transaction costs
tumor microenvironment
tumor necrosis factor alpha (TNFα)
tumor suppression
tumor-associated macrophages
tumor-immune cell interactions
tumorigenesis
tyrosine kinase 2
unfolded protein response (UPR)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui